Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma
PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has bee...
Saved in:
Published in | Cancer biomarkers : section A of Disease markers Vol. 20; no. 3; pp. 273 - 281 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
07.09.2017
Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1574-0153 1875-8592 1875-8592 |
DOI | 10.3233/CBM-170062 |
Cover
Abstract | PURPOSE:
The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC.
METHODS:
Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78.
RESULTS:
BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion.
CONCLUSION:
BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor. |
---|---|
AbstractList | The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC.PURPOSEThe glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC.Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78.METHODSStudy subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78.BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion.RESULTSBiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion.BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor.CONCLUSIONBiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor. The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor. PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. METHODS: Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. RESULTS: BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. CONCLUSION: BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor. PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in the endoplasmic reticulum (ER) and is extensively expressed in human neoplasms. Although the enhanced expression of BiP/GRP78 has been described to be associated with poor prognosis in gastric cancer (GC), details regarding its prognostic significance remain unclear. The aim of this study was to elucidate the prognostic role of BiP/GRP78 in patients with GC. METHODS: Study subjects included 328 patients who underwent surgical resection. Tumor specimens of primary tumors underwent immunohistochemical staining for BiP/GRP78. RESULTS: BiP/GRP78 was highly expressed in 57% (188/328) of patients. High expression of BiP/GRP78 was significantly associated with older age, male, disease staging, T factor, lymph node metastases, differentiation, lymphatic permeation, and vascular invasion. According to univariate analysis, age, disease staging, T factor, N factor, lymphatic permeation, vascular invasion, and BiP/GRP78 expression were significant prognostic factors for OS. In particular, high BiP/GRP78 expression was proven to be a significant predictor of prognosis in patients with older age, female sex, early disease stage, T1-2 factor, well or moderately differentiated tumors, and negative vascular invasion. CONCLUSION: BiP/GRP78 is significantly associated with tumor aggressiveness and progression. The increased expression of BiP/GRP78 was identified as an independent factor for predicting poor OS in patients with early stage of disease, especially T1-2 factor. |
Author | Yoshinari, Daisuke Shimizu, Akira Asao, Takayuki Oyama, Tetsunari Ogawa, Hiroomi Altan, Bolag Kaira, Kyoichi Takahashi, Kengo |
Author_xml | – sequence: 1 givenname: Hiroomi surname: Ogawa fullname: Ogawa, Hiroomi organization: , Gunma 371-8511 – sequence: 2 givenname: Kyoichi surname: Kaira fullname: Kaira, Kyoichi email: kkaira1970@yahoo.co.jp organization: , Gunma 371-8511 – sequence: 3 givenname: Kengo surname: Takahashi fullname: Takahashi, Kengo organization: , Gunma 371-8511 – sequence: 4 givenname: Akira surname: Shimizu fullname: Shimizu, Akira organization: , Gunma 371-8511 – sequence: 5 givenname: Bolag surname: Altan fullname: Altan, Bolag organization: , Gunma 371-8511 – sequence: 6 givenname: Daisuke surname: Yoshinari fullname: Yoshinari, Daisuke organization: , Gunma 371-8511 – sequence: 7 givenname: Takayuki surname: Asao fullname: Asao, Takayuki organization: , Gunma 371-8511 – sequence: 8 givenname: Tetsunari surname: Oyama fullname: Oyama, Tetsunari organization: , Gunma 371-8511 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28854502$$D View this record in MEDLINE/PubMed |
BookMark | eNptkdtKAzEQhoMoVqs3PoAEvFCE1Rx3N5daPIFiKXonLGmSrZFtUpMU9e1NqYpUb-bAfPMzzL8N1p13BoA9jE4oofR0cH5X4AqhkqyBLVxXvKi5IOu55hUrEOa0B7ZjfEGIUUzEJuiRuuaMI7IFnobBT5yPySoYfGegb-G5HZ5ejYZVDc37LJgYrXdQRngxgjEtemgdnMlkjUsRvtn0DCcyT7KE1MZ5JYOyzk_lDthoZRfN7lfug8fLi4fBdXF7f3UzOLstFGVVKsqy1LwSSHBEEddMMkNaloOoqaSs1cIYTfhYYkXGSGhVayFLOVZY06oUmPbB0VJ3Fvzr3MTUTG1UpuukM34eGywoIzXGFGX0YAV98fPg8nWZElRUBLGF4P4XNR9PjW5mwU5l-Gi-_5aB4yWggo8xmPYHwahZmNJkU5qlKRlGK7CyKb_PuxSk7f5fOVyuRDkxv078S34CDAyYLA |
CitedBy_id | crossref_primary_10_2174_1871520622666220823094350 crossref_primary_10_1016_j_cellsig_2023_110719 crossref_primary_10_1016_j_prp_2023_154301 crossref_primary_10_1166_jbn_2021_3107 crossref_primary_10_1155_2020_9430737 crossref_primary_10_1016_j_canlet_2019_01_034 crossref_primary_10_1021_acs_jafc_1c07927 crossref_primary_10_3892_ijo_2022_5431 crossref_primary_10_3389_fphys_2020_00177 crossref_primary_10_1038_s41420_022_00950_5 crossref_primary_10_15407_ubj91_03_065 crossref_primary_10_1515_oncologie_2023_0394 crossref_primary_10_1080_19490976_2021_2015238 crossref_primary_10_1016_j_bbcan_2022_188781 crossref_primary_10_2174_2212697X08666211006100250 crossref_primary_10_1002_adhm_202300913 |
Cites_doi | 10.1016/j.humpath.2007.11.009 10.1158/0008-5472.CAN-10-0339 10.1016/j.lungcan.2004.12.011 10.4161/cbt.5.7.2970 10.1016/j.yexmp.2014.02.011 10.1023/A:1006102411439 10.1007/s13277-016-5139-2 10.2174/156652406775574523 10.1186/1477-7819-12-121 10.1016/S0929-6646(10)60060-5 10.1016/0092-8674(94)90518-5 10.1016/j.urology.2009.05.007 10.4149/319_151002N513 10.1007/s10120-004-0289-0 10.1016/j.humpath.2007.03.014 10.1002/hed.21287 10.1007/s10585-006-9051-9 10.1016/j.ccr.2004.08.018 10.1007/s12072-014-9582-0 10.1073/pnas.0807691105 |
ContentType | Journal Article |
Copyright | 2017 – IOS Press and the authors. All rights reserved Copyright IOS Press BV 2017 |
Copyright_xml | – notice: 2017 – IOS Press and the authors. All rights reserved – notice: Copyright IOS Press BV 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 7U7 C1K H94 K9. 7X8 |
DOI | 10.3233/CBM-170062 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Oncogenes and Growth Factors Abstracts Toxicology Abstracts Nucleic Acids Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1875-8592 |
EndPage | 281 |
ExternalDocumentID | 28854502 10_3233_CBM_170062 10.3233_CBM-170062 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 123 29B 4.4 53G 6J9 AAFNC ABDBF ABJNI ABUBZ ACGFS ACHEB ACPQW ACPRK ACUHS ADZMO AEGXH AENEX AFRAH AFRHK AFRWT AGIAB ALMA_UNASSIGNED_HOLDINGS CAG COF DU5 EBD EBS EJD EMOBN ESX F5P H13 HZ~ IL9 IOS J8X MET MIO MV1 NGNOM O9- SAUOL SCNPE SFC SV3 TUS AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 7TO 7U7 C1K H94 K9. 7X8 |
ID | FETCH-LOGICAL-c347t-666d5790950305d4a4e2f44e2983a34fd9eed25ba1c2b09dc8d9a6abc1d376913 |
IEDL.DBID | AFRWT |
ISSN | 1574-0153 1875-8592 |
IngestDate | Fri Jul 11 00:40:02 EDT 2025 Mon Jun 30 08:14:12 EDT 2025 Thu Jan 02 23:11:43 EST 2025 Tue Jul 01 05:27:23 EDT 2025 Thu Apr 24 23:06:15 EDT 2025 Sun Jul 06 05:40:39 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | ER stress BiP GRP78 Gastric Cancer immunohistochemistry prognosis |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c347t-666d5790950305d4a4e2f44e2983a34fd9eed25ba1c2b09dc8d9a6abc1d376913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28854502 |
PQID | 1993972041 |
PQPubID | 2046387 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1934281130 proquest_journals_1993972041 pubmed_primary_28854502 crossref_primary_10_3233_CBM_170062 crossref_citationtrail_10_3233_CBM_170062 sage_journals_10_3233_CBM_170062 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-Sep-07 |
PublicationDateYYYYMMDD | 2017-09-07 |
PublicationDate_xml | – month: 09 year: 2017 text: 2017-Sep-07 day: 07 |
PublicationDecade | 2010 |
PublicationPlace | London, England |
PublicationPlace_xml | – name: London, England – name: Netherlands – name: London |
PublicationTitle | Cancer biomarkers : section A of Disease markers |
PublicationTitleAlternate | Cancer Biomark |
PublicationYear | 2017 |
Publisher | SAGE Publications Sage Publications Ltd |
Publisher_xml | – name: SAGE Publications – name: Sage Publications Ltd |
References | Desai 2004; 7 Takahashi 2016; 37 Zheng 2008; 39 Xia 2014; 12 Fu, Lee 2006; 5 Kaira 2016; 63 Hendershot 2004; 71 Gazit, Lu, Lee 1999; 54 Uramoto 2005; 49 Yang 2014; 96 Daneshmand 2007; 38 Arap 2004; 6 Fisher 1994; 78 Passarella 2010; 70 Lin 2010; 32 Huang 2010; 109 Zhang 2006; 23 Fu 2010; 75 Li, Lee 2006; 6 Vandewynckel 2015; 9 Uramoto (10.3233/CBM-170062_ref9) 2005; 49 Li (10.3233/CBM-170062_ref3) 2006; 6 Daneshmand (10.3233/CBM-170062_ref11) 2007; 38 Xia (10.3233/CBM-170062_ref5) 2014; 12 Huang (10.3233/CBM-170062_ref7) 2010; 109 Arap (10.3233/CBM-170062_ref21) 2004; 6 Gazit (10.3233/CBM-170062_ref4) 1999; 54 Vandewynckel (10.3233/CBM-170062_ref8) 2015; 9 Passarella (10.3233/CBM-170062_ref20) 2010; 70 Lin (10.3233/CBM-170062_ref6) 2010; 32 Yang (10.3233/CBM-170062_ref14) 2014; 96 Takahashi (10.3233/CBM-170062_ref15) 2016; 37 Fu (10.3233/CBM-170062_ref18) 2006; 5 Zhang (10.3233/CBM-170062_ref10) 2006; 23 Fisher (10.3233/CBM-170062_ref17) 1994; 78 Fu (10.3233/CBM-170062_ref12) 2010; 75 Desai (10.3233/CBM-170062_ref1) 2004; 7 10.3233/CBM-170062_ref19 Kaira (10.3233/CBM-170062_ref16) 2016; 63 Hendershot (10.3233/CBM-170062_ref2) 2004; 71 Zheng (10.3233/CBM-170062_ref13) 2008; 39 |
References_xml | – volume: 78 start-page: 539 year: 1994 end-page: 542 article-title: Apoptosis in cancer therapy: crossing the threshold publication-title: Cell – volume: 109 start-page: 326 year: 2010 end-page: 337 article-title: Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan publication-title: J Formos Med Assoc – volume: 49 start-page: 55 year: 2005 end-page: 62 article-title: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance publication-title: Lung Cancer – volume: 6 start-page: 45 year: 2006 end-page: 54 article-title: Stress induction of GRP78/BiP and its role in cancer publication-title: Curr Mol Med – volume: 23 start-page: 401 year: 2006 end-page: 410 article-title: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer publication-title: Clin Exp Metastasis – volume: 96 start-page: 235 year: 2014 end-page: 241 article-title: Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer publication-title: Exp Mol Pathol – volume: 12 start-page: 121 year: 2014 article-title: Glusose-rekated protein 78 and heparanase expression in oral squamous cell carcinoma: correlation and prognostic significance publication-title: World J Surg Oncol – volume: 75 start-page: 603 year: 2010 end-page: 607 article-title: Upregulation of GRP78 in renal cell carcinoma and its significance publication-title: Urology – volume: 71 start-page: 289 year: 2004 end-page: 297 article-title: The ER function BiP is a master regulator of ER function publication-title: Mt Sinai J Med – volume: 9 start-page: 93 year: 2015 end-page: 104 article-title: Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: A PERK for hepatocellular carcinoma therapy publication-title: Hepatol Int – volume: 39 start-page: 1042 year: 2008 end-page: 1049 article-title: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas publication-title: Hum Pathol – volume: 32 start-page: 1028 year: 2010 end-page: 1039 article-title: Positive association of glucose-related protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions publication-title: Head Neck – volume: 70 start-page: 4550 year: 2010 end-page: 4559 article-title: Targeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumors publication-title: Cancer Res – volume: 54 start-page: 135 year: 1999 end-page: 146 article-title: De-regulation of GRP stress protein expression in human breast cancer cell lines publication-title: Breast Cancer Res Treat – volume: 7 start-page: 201 year: 2004 end-page: 203 article-title: Improving outcomes in gastric cancer over 20 years publication-title: Gastric Cancer – volume: 6 start-page: 275 year: 2004 end-page: 284 article-title: Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands publication-title: Cancer Cell – volume: 38 start-page: 1547 year: 2007 end-page: 1552 article-title: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival publication-title: Hum Pathol – volume: 63 start-page: 477 year: 2016 end-page: 483 article-title: Prognostic significance of GRP78/BiP expression in patients with stage III/IV hypopharyngeal squamous cell carcinoma publication-title: Neoplasma – volume: 37 start-page: 13885 year: 2016 end-page: 13892 article-title: Clinical significance of Î2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma publication-title: Tumor Biol – volume: 5 start-page: 741 year: 2006 end-page: 744 article-title: Glucose regulated proteins in cancer progression, drug resistance and immunotherapy publication-title: Cancer Biol Ther – volume: 39 start-page: 1042 year: 2008 ident: 10.3233/CBM-170062_ref13 article-title: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas publication-title: Hum Pathol doi: 10.1016/j.humpath.2007.11.009 – volume: 70 start-page: 4550 year: 2010 ident: 10.3233/CBM-170062_ref20 article-title: Targeted nanoparticles that deliver a sustained, specific release of paclitaxel to irradiated tumors publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-10-0339 – volume: 49 start-page: 55 year: 2005 ident: 10.3233/CBM-170062_ref9 article-title: Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance publication-title: Lung Cancer doi: 10.1016/j.lungcan.2004.12.011 – volume: 5 start-page: 741 year: 2006 ident: 10.3233/CBM-170062_ref18 article-title: Glucose regulated proteins in cancer progression, drug resistance and immunotherapy publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.7.2970 – volume: 96 start-page: 235 year: 2014 ident: 10.3233/CBM-170062_ref14 article-title: Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer publication-title: Exp Mol Pathol doi: 10.1016/j.yexmp.2014.02.011 – volume: 54 start-page: 135 year: 1999 ident: 10.3233/CBM-170062_ref4 article-title: De-regulation of GRP stress protein expression in human breast cancer cell lines publication-title: Breast Cancer Res Treat doi: 10.1023/A:1006102411439 – volume: 37 start-page: 13885 year: 2016 ident: 10.3233/CBM-170062_ref15 article-title: Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma publication-title: Tumor Biol doi: 10.1007/s13277-016-5139-2 – volume: 6 start-page: 45 year: 2006 ident: 10.3233/CBM-170062_ref3 article-title: Stress induction of GRP78/BiP and its role in cancer publication-title: Curr Mol Med doi: 10.2174/156652406775574523 – volume: 12 start-page: 121 year: 2014 ident: 10.3233/CBM-170062_ref5 article-title: Glusose-rekated protein 78 and heparanase expression in oral squamous cell carcinoma: correlation and prognostic significance publication-title: World J Surg Oncol doi: 10.1186/1477-7819-12-121 – volume: 109 start-page: 326 year: 2010 ident: 10.3233/CBM-170062_ref7 article-title: Decreased GRP78 protein expression is a potential prognostic marker of oral squamous cell carcinoma in Taiwan publication-title: J Formos Med Assoc doi: 10.1016/S0929-6646(10)60060-5 – volume: 78 start-page: 539 year: 1994 ident: 10.3233/CBM-170062_ref17 article-title: Apoptosis in cancer therapy: crossing the threshold publication-title: Cell doi: 10.1016/0092-8674(94)90518-5 – volume: 75 start-page: 603 year: 2010 ident: 10.3233/CBM-170062_ref12 article-title: Upregulation of GRP78 in renal cell carcinoma and its significance publication-title: Urology doi: 10.1016/j.urology.2009.05.007 – volume: 63 start-page: 477 year: 2016 ident: 10.3233/CBM-170062_ref16 article-title: Prognostic significance of GRP78/BiP expression in patients with stage III/IV hypopharyngeal squamous cell carcinoma publication-title: Neoplasma doi: 10.4149/319_151002N513 – volume: 7 start-page: 201 year: 2004 ident: 10.3233/CBM-170062_ref1 article-title: Improving outcomes in gastric cancer over 20 years publication-title: Gastric Cancer doi: 10.1007/s10120-004-0289-0 – volume: 38 start-page: 1547 year: 2007 ident: 10.3233/CBM-170062_ref11 article-title: Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival publication-title: Hum Pathol doi: 10.1016/j.humpath.2007.03.014 – volume: 71 start-page: 289 year: 2004 ident: 10.3233/CBM-170062_ref2 article-title: The ER function BiP is a master regulator of ER function publication-title: Mt Sinai J Med – volume: 32 start-page: 1028 year: 2010 ident: 10.3233/CBM-170062_ref6 article-title: Positive association of glucose-related protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions publication-title: Head Neck doi: 10.1002/hed.21287 – volume: 23 start-page: 401 year: 2006 ident: 10.3233/CBM-170062_ref10 article-title: Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer publication-title: Clin Exp Metastasis doi: 10.1007/s10585-006-9051-9 – volume: 6 start-page: 275 year: 2004 ident: 10.3233/CBM-170062_ref21 article-title: Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.08.018 – volume: 9 start-page: 93 year: 2015 ident: 10.3233/CBM-170062_ref8 article-title: Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: A PERK for hepatocellular carcinoma therapy publication-title: Hepatol Int doi: 10.1007/s12072-014-9582-0 – ident: 10.3233/CBM-170062_ref19 doi: 10.1073/pnas.0807691105 |
SSID | ssj0043129 |
Score | 2.1910975 |
Snippet | PURPOSE:
The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular... The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular chaperone in... PURPOSE: The glucose-regulated protein 78 (GRP78), also referred to as immunoglobulin heavy chain binding protein (BiP) (BiP/GRP78), is a major molecular... |
SourceID | proquest pubmed crossref sage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 273 |
SubjectTerms | Adenocarcinoma Adenocarcinoma - genetics Adenocarcinoma - metabolism Adenocarcinoma - pathology Adult Age Aged Aged, 80 and over Endoplasmic reticulum Endoplasmic Reticulum Stress - physiology Female Gastric cancer Heat-Shock Proteins - biosynthesis Heat-Shock Proteins - genetics Humans Immunohistochemistry Lymph nodes Male Medical prognosis Metastases Middle Aged Neoplasms Patients Penetration Prognosis Stomach Neoplasms - genetics Stomach Neoplasms - metabolism Stomach Neoplasms - pathology Tumors Young Adult |
Title | Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma |
URI | https://journals.sagepub.com/doi/full/10.3233/CBM-170062 https://www.ncbi.nlm.nih.gov/pubmed/28854502 https://www.proquest.com/docview/1993972041 https://www.proquest.com/docview/1934281130 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSyQxEC58gHhZ1ufOrkoWvXjodZL0IzmJo46yoAyDooeFJpPHKjjdyzxg999v1XT34Au89KFTJKGSSlWlvlQBHKAbGxy6x5FvaxvFgttIBXRc0-BlqhMTuJ-hfK_Ty9v4531yvwAPzVuYmoPjHwSrwhnNDmuSbrqNJhGXQsqj085VRInlUnE8nQzz6p67KadBfygwPR1STNsSEvJf1LxrW4RlqsKEIrx80u3f3TSnNurRWUUznmSEykhklcr01Wgvldcbi_QFGmymoLqf4VNtWbKTaiuswYIv1mHlqo6db8Cv3qgkVB02M8IUsjKwzmPv6KLfyxTzf2tEbMHMmJ33WfWIhD0WrE69OmZ0Z8t-G6r0YZnBAwv14Ag7L4dmE2675zenl1FdWyGyMs4mEXotLsk0Glgk8S42sRchxo9W0sg4OI3KUyQDw60YtLWzymmTmoHlDo8kzeUWLBVl4b8As0KoENDS8MrFIXCtDPe27Z0XSqF714LDhmm5rROPU_2LpxwdEGJwjgzOKwa3YH9O-6dKt_Eu1U7D-7zZMDkhETWV3OEt-D5vRmGhCIgpfDklGonuFke93YLtas3mw-Bk0ZpsY-eMFvFZx2_G__oxyTdYFWQAUOgp24GlyWjqd9F8mQz2cOd1zjrdvXoH_gezf-zX |
linkProvider | SAGE Publications |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxELYQSJRLBbSFlJcruHBYiB-btY-ACKElKIqC4FBp5fiBItHdKgkSP5-ZXSfiJXHZi2dta8aeh_15hpADCGODg_A48U1tE8mZTVSAwLUVvGjp1ATmK5TvdatzI3_fpXfxHTe-hYkcnBwhrApmVCnruLsFF-L47LSbYE451LtLMq28oqWTdv92MFPAYBKr4mQszRBgkYo6K-mbv1_boXfO5StgV2Vr2qvka3QS6Ukt1TWy4It1styN1-DfyN_euESAHDRThAfSMtDTUe_4ot_LFPVPEdxaUDOh531avweho4LGLKoTisev9N5g0Q5LDegeMGlj6Lz8Z76Tm_b54KyTxDIJiRUymyYQgLg00-Ar4eZ10kjPg4SPVsIIGZwGO8jToWGWD5vaWeW0aZmhZQ60i2biB1ksysJvEmo5VyGA0-CVkyEwrQzztumd50pBpNYghzOm5TbmEMdSFg85xBLI4BwYnNcMbpD9Oe3_OnPGh1TbM97nM9nnCCrUWD2HNciveTOse7zMMIUvH5FGQOTEwAQ3yEYts_kwMFlwDJvQOUUhvuj43fg_PyfZI186g-5VfnV5_WeLrHC063ijlG2Txen40e-AVzId7sZV-AyJO9jL |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTxsxEB5VQUK9VJS2NDRQo_bSw5b4sVn7yCtAW1AUgcoBaeX4UUVqd1EeUn8-M1knKlCJy148a1sz9jzszzMAnzGMjR7D4yx0jcuU4C7TEQPXXgyyZ3IbeVigfC97Z9fq201-k44u6C1M4uD0K8GqcEYLZU27-85H2uFSSLl_dHiRUV450r1riorntmDtoD_8ebVUwmgWFwXKeF4QyCKXTWbSR38_tEVPHMwH4K6FvelvwKvkKLKDRrKv4UWoNmH9Il2Fv4HbwaQmkBw2M4IIsjqyw_Fg_3Q4KDQLfxPAtWJ2yk6GrHkTwsYVS5lUp4yOYNkvS4U7HLOof9CsTbDz-o99C9f9k6ujsyyVSsicVMUswyDE54VBf4k2sFdWBREVfoyWVqroDdpCkY8sd2LUNd5pb2zPjhz3qGEMl--gVdVVeA_MCaFjRMchaK9i5EZbHlw3-CC0xmitDV-WTCtdyiNO5Sx-lxhPEINLZHDZMLgNn1a0d032jP9SdZa8L5fyLwlYaKiCDm_D3qoZ1z5daNgq1HOikRg9cTTDbdhqZLYaBieLzmEXO2ckxH86fjL-9vMkH2F9cNwvf5xffv8ALwWZdrpUKjrQmk3mYQcdk9loNy3Ce-_S2eQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+role+of+BiP%2FGRP78+expression+as+ER+stress+in+patients+with+gastric+adenocarcinoma&rft.jtitle=Cancer+biomarkers+%3A+section+A+of+Disease+markers&rft.au=Ogawa%2C+Hiroomi&rft.au=Kaira%2C+Kyoichi&rft.au=Takahashi%2C+Kengo&rft.au=Shimizu%2C+Akira&rft.date=2017-09-07&rft.eissn=1875-8592&rft.volume=20&rft.issue=3&rft.spage=273&rft_id=info:doi/10.3233%2FCBM-170062&rft_id=info%3Apmid%2F28854502&rft.externalDocID=28854502 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1574-0153&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1574-0153&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1574-0153&client=summon |